Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies

Deepa Sampath, Asifa Malik, William Plunkett, Billie Nowak, Betsy Williams, Michelle Burton, Srdan Verstovsek, Stefan Faderl, Guillermo Garcia-Manero, Alan F. List, Said Sebti, Hagop M. Kantarjian, Farhad Ravandi, Jeffrey E. Lancet

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences